A recent study, published in Nature Genetics, looked at the genetic information of many people from different parts of the world to see if inherited differences play a role in Long COVID.

• The study used a method called Genome-Wide Association Study (GWAS). 
• This method scans our DNA for tiny “spelling mistakes” (called single-nucleotide polymorphisms or SNPs) that are more common in people with a certain condition.

What is Long COVID?

• Long COVID refers to symptoms that persist for weeks or months after recovering from COVID-19.
• According to the World Health Organization (WHO), the most common Long COVID symptoms are fatigue, breathlessness and issues with mental focus. 
• As of now, there is no specific drug treatment for Long COVID.

The Key Finding: A Gene Linked to Long COVID Risk

• FOXP4 Gene Connection: The study found a strong link between Long COVID and a specific area on chromosome 6, which is near the FOXP4 gene.
• Specific Variant Identified: A particular variant in this region, called rs9367106, was found to increase the risk of Long COVID. People with the “C” version of this variant were about 63% more likely to have Long COVID symptoms.
• Not Just for Severe Cases: This FOXP4 gene increased Long COVID risk even in people who weren’t seriously ill or hospitalized, suggesting its effect isn’t only tied to how severe the initial infection was.
• Varying Across Populations: The frequency of this variant differed across different groups of people. For example, it was found in about 1.6% of non-Finnish Europeans but in up to 36% of East Asians.

What Does FOXP4 Do? From Lungs to Immunity

• Active in Lung Tissue: The genetic variant linked to Long COVID is in a part of DNA that is very “active” in lung tissue. This suggests it might affect how the lungs work.
• Impact on Lung Cells: FOXP4 is highly active in type 2 alveolar cells in the lungs. These cells are crucial for keeping air sacs open, clearing fluids, and repairing damaged tissue. They also play a role in how the immune system responds to viruses like SARS-CoV-2.
• Higher FOXP4 Levels, Higher Risk: Researchers also found that people with moderately higher levels of FOXP4 in their blood (even after the initial infection cleared) were more than twice as likely to develop Long COVID. 

DOWNLOAD PDF